10-89223823-A-G

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_000235.4(LIPA):ā€‹c.683T>Cā€‹(p.Phe228Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000126 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00065 ( 0 hom., cov: 32)
Exomes š‘“: 0.000072 ( 0 hom. )

Consequence

LIPA
NM_000235.4 missense

Scores

4
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:1

Conservation

PhyloP100: 6.50
Variant links:
Genes affected
LIPA (HGNC:6617): (lipase A, lysosomal acid type) This gene encodes lipase A, the lysosomal acid lipase (also known as cholesterol ester hydrolase). This enzyme functions in the lysosome to catalyze the hydrolysis of cholesteryl esters and triglycerides. Mutations in this gene can result in Wolman disease and cholesteryl ester storage disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.021826178).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00065 (99/152296) while in subpopulation AFR AF= 0.00214 (89/41558). AF 95% confidence interval is 0.00178. There are 0 homozygotes in gnomad4. There are 52 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LIPANM_000235.4 linkuse as main transcriptc.683T>C p.Phe228Ser missense_variant 7/10 ENST00000336233.10 NP_000226.2 P38571-1
LIPANM_001127605.3 linkuse as main transcriptc.683T>C p.Phe228Ser missense_variant 7/10 NP_001121077.1 P38571-1
LIPANM_001288979.2 linkuse as main transcriptc.335T>C p.Phe112Ser missense_variant 5/8 NP_001275908.1 P38571A0A0A0MT32
LIPAXM_024448023.2 linkuse as main transcriptc.683T>C p.Phe228Ser missense_variant 7/10 XP_024303791.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LIPAENST00000336233.10 linkuse as main transcriptc.683T>C p.Phe228Ser missense_variant 7/101 NM_000235.4 ENSP00000337354.5 P38571-1
LIPAENST00000428800.5 linkuse as main transcriptc.683T>C p.Phe228Ser missense_variant 6/71 ENSP00000388415.1 Q5T073
LIPAENST00000371837.5 linkuse as main transcriptc.515T>C p.Phe172Ser missense_variant 6/92 ENSP00000360903.1 P38571-2
LIPAENST00000456827.5 linkuse as main transcriptc.335T>C p.Phe112Ser missense_variant 5/83 ENSP00000413019.2 A0A0A0MT32

Frequencies

GnomAD3 genomes
AF:
0.000657
AC:
100
AN:
152178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.000207
AC:
52
AN:
250964
Hom.:
0
AF XY:
0.000206
AC XY:
28
AN XY:
135748
show subpopulations
Gnomad AFR exome
AF:
0.00253
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000654
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000718
AC:
105
AN:
1461820
Hom.:
0
Cov.:
32
AF XY:
0.0000729
AC XY:
53
AN XY:
727214
show subpopulations
Gnomad4 AFR exome
AF:
0.00233
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000450
Gnomad4 OTH exome
AF:
0.000199
GnomAD4 genome
AF:
0.000650
AC:
99
AN:
152296
Hom.:
0
Cov.:
32
AF XY:
0.000698
AC XY:
52
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.00214
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.000111
Hom.:
0
Bravo
AF:
0.000722
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000222
AC:
27

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Lysosomal acid lipase deficiency Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterMay 10, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingCounsylFeb 09, 2017- -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 05, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicAug 13, 2024BS1 -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 01, 2023Variant summary: LIPA c.683T>C (p.Phe228Ser) results in a non-conservative amino acid change located in the alpha/beta hydrolase fold-1 domain (IPR000073) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00021 in 250964 control chromosomes, predominantly at a frequency of 0.0025 within the African or African-American subpopulation in the gnomAD database. This frequency is approximately equal to the estimated maximal expected allele frequency for a pathogenic variant in LIPA causing Lysosomal Acid Lipase Deficiency (0.00021 vs 0.0027), suggesting it could be a benign polymorphism found predominately in individuals of African ancestry. c.683T>C has been reported in the literature in the heterozygous state in two individuals affected with familial hypercholesterolemia, but no diagnosis of Lysosomal Acid Lipase Deficiency (Sjouke_2016). This report does not provide unequivocal conclusions about association of the variant with Lysosomal Acid Lipase Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32041611, 27423329). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Three submitters classified the variant as uncertain significance and one classified it as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. -
LIPA-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 09, 2024The LIPA c.683T>C variant is predicted to result in the amino acid substitution p.Phe228Ser. This variant has been reported in two individuals with hypercholesterolaemia and in an individual from a cohort being studied for dyslipidemia (Table 2, Sjouke et al. 2016. PubMed ID: 27423329; Table S4, Dron et al. 2020. PubMed ID: 32041611). This variant is reported in 0.25% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 21, 2024The p.F228S variant (also known as c.683T>C), located in coding exon 6 of the LIPA gene, results from a T to C substitution at nucleotide position 683. The phenylalanine at codon 228 is replaced by serine, an amino acid with highly dissimilar properties. This variant has been reported in a familial hypercholesterolemia (FH) cohort (Sjouke B et al. Atherosclerosis, 2016 Aug;251:263-265). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Wolman disease Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.033
T
BayesDel_noAF
Pathogenic
0.17
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.35
T;.;T;.
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.78
T;T;T;T
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.022
T;T;T;T
MetaSVM
Uncertain
0.11
D
MutationAssessor
Uncertain
2.8
M;.;.;.
PrimateAI
Benign
0.44
T
PROVEAN
Pathogenic
-4.9
D;D;.;D
REVEL
Uncertain
0.52
Sift
Benign
0.071
T;T;.;T
Sift4G
Uncertain
0.053
T;D;T;.
Polyphen
0.55
P;D;.;.
Vest4
0.90
MVP
0.93
MPC
0.81
ClinPred
0.13
T
GERP RS
4.4
Varity_R
0.73
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2228159; hg19: chr10-90983580; API